Vanguard Group Inc. lessened its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report) by 22.8% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,940,071 shares of the company’s stock after selling 1,164,585 shares during the period. Vanguard Group Inc. owned about 0.08% of Nu Skin Enterprises worth $27,147,000 as of its most recent filing with the SEC.
Several other large investors have also recently bought and sold shares of the stock. JPMorgan Chase & Co. increased its position in shares of Nu Skin Enterprises by 175.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 231,957 shares of the company’s stock worth $1,710,000 after purchasing an additional 147,784 shares during the last quarter. Bank of New York Mellon Corp grew its stake in shares of Nu Skin Enterprises by 18.5% in the fourth quarter. Bank of New York Mellon Corp now owns 613,330 shares of the company’s stock valued at $4,226,000 after buying an additional 95,938 shares in the last quarter. American Century Companies Inc. increased its holdings in Nu Skin Enterprises by 12.0% during the fourth quarter. American Century Companies Inc. now owns 824,739 shares of the company’s stock worth $5,682,000 after buying an additional 88,181 shares during the last quarter. AlphaQuest LLC raised its position in Nu Skin Enterprises by 197.8% during the fourth quarter. AlphaQuest LLC now owns 108,204 shares of the company’s stock worth $746,000 after acquiring an additional 71,864 shares in the last quarter. Finally, Barclays PLC lifted its stake in Nu Skin Enterprises by 363.8% in the third quarter. Barclays PLC now owns 85,437 shares of the company’s stock valued at $629,000 after acquiring an additional 67,016 shares during the last quarter. 82.84% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on the stock. StockNews.com lowered shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Tuesday, April 8th. DA Davidson lowered their price target on Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research report on Friday, December 20th.
Nu Skin Enterprises Trading Down 2.9 %
Shares of Nu Skin Enterprises stock opened at $6.05 on Tuesday. Nu Skin Enterprises, Inc. has a 1 year low of $5.75 and a 1 year high of $14.00. The company has a market capitalization of $300.82 million, a price-to-earnings ratio of -2.05 and a beta of 1.10. The business has a fifty day simple moving average of $7.27 and a two-hundred day simple moving average of $7.02. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.82 and a quick ratio of 1.17.
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last posted its earnings results on Thursday, February 13th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. The company had revenue of $445.55 million during the quarter, compared to analysts’ expectations of $441.10 million. Research analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current year.
Nu Skin Enterprises Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Wednesday, March 5th. Stockholders of record on Monday, February 24th were paid a dividend of $0.06 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.97%. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently -8.14%.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Featured Articles
- Five stocks we like better than Nu Skin Enterprises
- What is diluted earnings per share (Diluted EPS)?
- Why NVIDIA Stock Could Soar Despite Wall Street Downgrades
- What is MarketRank� How to Use it
- Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold
- How to Use the MarketBeat Stock Screener
- 3 Hot New IPOs Defying the 2025 Market Slump
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.